Related Experiment Video
Updated: Sep 28, 2026
An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Results of interval debulking surgery in advanced stage ovarian cancer: an exposed-non-exposed study
P Morice1, D Brehier-Ollive, A Rey
1Department of Surgery, Institut Gustave Roussy, Villejuif, France. morice@igr.fr
Background:
To study the results of interval debulking surgery (IDS) in patients treated for 'unresectable' advanced stage ovarian cancer compared with primary debulking surgery (PDS) followed by chemotherapy.
Patients And Methods:
An exposed-non-exposed study including a group of 34 patients who underwent an IDS and were matched to an historic control group of 34 patients treated with PDS.
Results:
Optimal cytoreductive surgery was achieved in 94% (32 out of 34) of patients in both groups. The rates of post-operative morbidity, blood transfusion and median length of hospitalisation were significantly reduced in the study (IDS) group, but survival did not differ in both groups.
Conclusions:
IDS in patients with advanced stage ovarian cancer offers the same chance of survival as PDS, but it is better tolerated.
